In a study by Nachbagauer et al.78, RIV4 induced HA stem
specificneutralisingantibodiesdirectedagainstinfluenzasubtype
H1, H3 and B haemagglutinin in an age-dependent manner i
humans,withthehighesttitresobservedintheelderly78.RIV4als
inducesantibodies,inbothhumansandmice,thatarespecifict
epitopes in the HA head region, at greater proportions than
traditional mammalian cell-derived subunit vaccine (Flucelvax
[Trivalent])77. Higher magnitudes of haemagglutination inhibitor
antibodyresponseagainstHA1havealsobeenobservedwithRIV
compared to egg- or mammalian cell-derived split vaccine
(Flucelvax® Tetra, Seqirus, and Fluzone® quadrivalent SD, Sano
Pasteur)60.Thesedatawarrantadditionalstudiestoverifywhethe
rHA elicits a broader antibody repertoire than convention
vaccines and whether this underlies the cross-protection agains
12,81